HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R A DeFronzo Selected Research
R A DeFronzo Research Topics
Disease
25
Insulin Resistance
08/2015 - 02/2000
24
Type 2 Diabetes Mellitus (MODY)
11/2021 - 02/2000
8
Body Weight (Weight, Body)
10/2013 - 08/2000
4
Weight Gain
03/2015 - 10/2011
4
Glucose Intolerance
10/2013 - 09/2003
3
Weight Loss (Weight Reduction)
03/2015 - 10/2011
3
Obesity
08/2013 - 08/2000
2
Hyperglycemia
06/2011 - 03/2001
2
Atherosclerosis
07/2010 - 10/2004
1
Cardiovascular Diseases (Cardiovascular Disease)
05/2016
1
Myocardial Infarction
05/2016
1
Stroke (Strokes)
05/2016
1
Pediatric Obesity
08/2015
1
Diabetes Mellitus
05/2015
1
Bone Fractures (Bone Fracture)
10/2013
1
Prediabetic State (Prediabetes)
10/2013
1
Overweight
08/2013
1
Hypoglycemia (Reactive Hypoglycemia)
03/2013
1
Inflammation (Inflammations)
05/2011
1
Necrosis
12/2008
1
Albuminuria
12/2007
1
Hyperinsulinism (Hyperinsulinemia)
05/2001
Drug/Important Bio-Agent (IBA)
21
Glucose (Dextrose)
FDA Link
Generic
03/2015 - 02/2000
18
Insulin (Novolin)
FDA Link
08/2013 - 02/2000
9
Pioglitazone (Actos)
FDA Link
11/2021 - 04/2001
4
Metformin (Glucophage)
FDA Link
Generic
11/2021 - 12/2006
4
Exenatide (Byetta)
FDA Link
11/2021 - 12/2006
4
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
05/2015 - 10/2004
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2013 - 12/2007
4
Lipids
IBA
07/2010 - 10/2004
3
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2021 - 01/2012
3
Rosiglitazone (Avandia)
FDA Link
12/2008 - 12/2001
3
Nonesterified Fatty Acids (NEFA)
IBA
12/2008 - 12/2001
3
Adiponectin
IBA
12/2008 - 05/2004
2
Pharmaceutical Preparations
IBA
11/2021 - 03/2015
2
Insulin Glargine (Lantus)
FDA Link
11/2021 - 03/2015
2
Triglycerides (Triacylglycerol)
IBA
08/2015 - 12/2008
2
Biomarkers (Surrogate Marker)
IBA
08/2015 - 05/2011
2
muraglitazar
IBA
05/2015 - 10/2011
2
Cytokines
IBA
08/2013 - 10/2004
2
Thiazolidinediones
IBA
07/2010 - 10/2004
2
Phosphotransferases (Kinase)
IBA
07/2010 - 02/2000
2
Adipokines
IBA
12/2008 - 10/2004
2
C-Peptide
IBA
12/2008 - 09/2003
1
Glipizide (Glucotrol)
FDA Link
Generic
11/2021
1
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
11/2021
1
empagliflozin
IBA
05/2016
1
omega-Chloroacetophenone (Mace)
IBA
05/2016
1
HDL Cholesterol
IBA
08/2015
1
Glucagon (Glukagon)
FDA Link
08/2013
1
Interleukin-6 (Interleukin 6)
IBA
08/2013
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
03/2013
1
Dipeptidyl-Peptidase IV Inhibitors
IBA
05/2012
1
alogliptin
IBA
05/2012
1
Proinsulin
IBA
05/2012
1
5'-palmitoyl cytarabine (PLAC)
IBA
10/2011
1
Mitogen-Activated Protein Kinases
IBA
07/2010
1
Diglycerides
IBA
07/2010
1
Ceramides
IBA
07/2010
1
Acyl Coenzyme A (Acyl CoA)
IBA
07/2010
1
Aligeron (AS 2)
IBA
03/2010
1
Tissue Inhibitor of Metalloproteinase-3
IBA
10/2009
1
ADAM17 Protein
IBA
10/2009
1
Type I Tumor Necrosis Factor Receptors
IBA
10/2009
1
Palmitates
IBA
10/2009
1
Leptin
IBA
12/2008
1
LDL Cholesterol
IBA
12/2008
1
PPAR-gamma Agonists
IBA
08/2007
1
PPAR alpha
IBA
08/2007
1
Incretins
IBA
12/2006
1
PPAR gamma
IBA
10/2004
1
Resistin
IBA
06/2004
1
Adiponectin Receptors
IBA
05/2004
1
Tyrosine (L-Tyrosine)
FDA Link
11/2001
1
Insulin Receptor Substrate Proteins
IBA
11/2001
1
Insulin Receptor
IBA
11/2001
1
Glycogen Synthase (Synthase I)
IBA
05/2001
1
Glucose Transporter Type 4
IBA
05/2001
1
Glycogen
IBA
05/2001
1
Messenger RNA (mRNA)
IBA
05/2001
1
Hexokinase
IBA
05/2001
1
Vanadium
IBA
03/2001
1
Hemoglobin A
IBA
03/2001
1
Fructosamine
IBA
03/2001
1
vanadyl sulfate
IBA
03/2001
1
Bromocriptine (Parlodel)
FDA Link
Generic
08/2000
1
Neurotransmitter Agents (Neurotransmitter)
IBA
08/2000
1
Phosphatidylinositol 3-Kinases (PI 3 Kinase)
IBA
02/2000
Therapy/Procedure
6
Therapeutics
11/2021 - 07/2000
6
Glycemic Control
03/2013 - 03/2001
1
Aftercare (After-Treatment)
03/2001